Literature DB >> 316436

Changes in T and B blood lymphocytes after splenectomy.

R E Millard, D K Banerjee.   

Abstract

The blood lymphocytes of 37 splenectomised patients were analysed by means of T and B lymphocyte surface markers. Sixteen patients had had a splenectomy for non-haematological and 21 for haematological reasons. The results show that 15 had normal numbers of T and B cells; decreased T cells were found in two patients, raised B cells in seven, raised T and B cells in eight, and raised T cells in five patients. Increased numbers of 'null' cells were observed in some patients, especially in those with raised B cells. Follow-up studies indicate that raised levels of T and B cells can be established by one to three months post-splenectomy and may persist, although in some patients the cells fall to normal levels. The lymphocyte proliferative response to phytohaemagglutinin and Concanavalin A in vitro was normal in eight out of nine patients with raised T cells and was depressed in one patient, possibly due to an intrinsic cell defect.

Entities:  

Mesh:

Year:  1979        PMID: 316436      PMCID: PMC1145889          DOI: 10.1136/jcp.32.10.1045

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Acid phosphatase activity in human blood cells.

Authors:  A F GOLDBERG; T BARKA
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

2.  The postsplenectomy blood picture.

Authors:  R L LIPSON; E D BAYRD; C H WATKINS
Journal:  Am J Clin Pathol       Date:  1959-12       Impact factor: 2.493

3.  An analytical study of splenectomized cases after traumatic rupture of healthy spleens.

Authors:  J I EK; S RAYNER
Journal:  Acta Med Scand       Date:  1950

4.  Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia.

Authors:  D Catovsky; J Galetto; A Okos; E Miliani; D A Galton
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

5.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

6.  The effect of splenectomy on the leucocyte count.

Authors:  J A McBride; J V Dacie; R Shapley
Journal:  Br J Haematol       Date:  1968-02       Impact factor: 6.998

7.  IgG on lymphocyte surfaces; technical problems and the significance of a third cell population.

Authors:  R J Winchester; S M Fu; T Hoffman; H G Kunkel
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

8.  Identification of two populations of immunoglobulin-bearing lymphocytes in man.

Authors:  P I Lobo; F B Westervelt; D A Horwitz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  On the late effects of removal of the normal spleen. A follow-up study of 40 persons.

Authors:  B Pedersen; A Videbaek
Journal:  Acta Chir Scand       Date:  1966 Jan-Feb

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

  10 in total
  5 in total

1.  Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.

Authors:  Q Mok; G Underhill; B Wonke; M Aldouri; M Kelsey; D Jefferies
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

2.  Autotransplantation of splenic fragments: lymphocyte subsets in blood, lymph nodes and splenic tissue.

Authors:  J Westermann; R Pabst
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  Increased total serum IgE concentration in patients who have undergone splenectomy after trauma.

Authors:  G Chelazzi; G Pinotti; C Nicora; D Rossi; G Senaldi
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.

Authors:  De-Hyung Lee; Anne Waschbisch; Alexandra B Lämmer; Arnd Doerfler; Stefan Schwab; Ralf A Linker
Journal:  J Neuroinflammation       Date:  2013-10-09       Impact factor: 8.322

5.  Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice.

Authors:  Prodyot K Chatterjee; Michael M Yeboah; Malvika H Solanki; Gopal Kumar; Xiangying Xue; Valentin A Pavlov; Yousef Al-Abed; Christine N Metz
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.